Keensight-backed Symeres snaps up Exemplify BioPharma

Exemplify BioPharma is Symeres’ second acquisition in the US this year.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this